Alvotech SA
NASDAQ:ALVO
Alvotech SA
Long-Term Investments
Alvotech SA
Long-Term Investments Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Long-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
A
|
Alvotech SA
NASDAQ:ALVO
|
Long-Term Investments
$18.5m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Alvotech SA
Glance View
In the fiercely competitive world of pharmaceuticals, Alvotech SA has carved out a distinct niche as a specialist in developing biosimilars—essentially highly similar alternatives to already approved biological medicines. Based in Iceland, the company was founded by Robert Wessman, renowned for his successful ventures in the pharmaceutical industry. Alvotech strives to not only make crucial medications more accessible but to also alleviate the strain of high drug costs on healthcare systems worldwide. With its ardent focus on quality and efficacy, Alvotech's innovative research and development strategies underline its commitment to replicating complex biologics, ensuring they are more affordable without compromising on safety and effectiveness. Alvotech’s business model is intricately woven into the fabric of collaboration and partnership. Rather than attempting to market its products independently, Alvotech aligns with a network of global partners for commercialization and distribution, allowing the company to reach diverse markets efficiently. This approach not only widens their reach but also minimizes the cost and time associated with entering new geographical territories. Alvotech generates revenue by selling these biosimilars, capitalizing on the expiration of patents on original biologic drugs. In doing so, it provides healthcare providers and patients with cost-effective options, positioning itself as a valuable player in the increasingly essential biosimilar market.
See Also
What is Alvotech SA's Long-Term Investments?
Long-Term Investments
18.5m
USD
Based on the financial report for Dec 31, 2023, Alvotech SA's Long-Term Investments amounts to 18.5m USD.
What is Alvotech SA's Long-Term Investments growth rate?
Long-Term Investments CAGR 3Y
-31%
Over the last year, the Long-Term Investments growth was -62%. The average annual Long-Term Investments growth rates for Alvotech SA have been -31% over the past three years .